Filter
1195
Text search:
molecular
testing
Featured
Recommendations
170
New Publications
232
Language
Document type
No document type
518
Guidelines
271
Studies & Reports
221
Manuals
72
Strategic & Response Plan
54
Fact sheets
28
Training Material
16
Situation Updates
8
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
India
72
Global
48
Western and Central Europe
41
Latin America and the Carribbean
31
Eastern Europe
24
Kenya
23
South Africa
22
Africa
22
Ethiopia
18
Tanzania
18
Brazil
13
East and Southern Africa
12
West and Central Africa
12
Malawi
11
Namibia
11
Russia
11
Uganda
10
Zambia
10
Rwanda
10
Sierra Leone
9
Nigeria
9
South–East Asia Region
9
Asia
9
Liberia
8
Philippines
8
Colombia
8
Zimbabwe
7
Nepal
7
Mozambique
7
Peru
7
Ghana
6
Bangladesh
6
Argentina
6
Myanmar / Burma
6
Congo, Democratic Republic of
5
Germany
5
Indonesia
5
Ukraine
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Vietnam
5
Senegal
4
USA
4
Pakistan
4
Syria
4
Cambodia
4
Angola
4
Middle East and North Africa
4
Guinea-Bissau
3
Eswatini/ Swaziland
3
Ecuador
3
Botswana
3
El Salvador
3
Chile
3
Spain
3
Guinea
2
Burkina Faso
2
Cameroon
2
South Sudan
2
Lebanon
2
Turkey
2
Bolivia
2
Venezuela
2
Tajikistan
2
Georgia
2
North America
2
Haiti
1
Somalia
1
Jordan
1
Afghanistan
1
Thailand
1
Gambia
1
China
1
Benin
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Laos
1
Timor Leste/ East Timor
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
349
Clinical Guidelines
163
Pharmacy & Technologies
56
Public Health
45
Key Resources
24
Women & Child Health
13
Capacity Building
7
Toolboxes
TB
263
COVID-19
158
NTDs
89
HIV
88
AMR
81
Malaria
41
Rapid Response
39
Ebola & Marburg
34
Mental Health
29
Zika
21
Planetary Health
21
Pharmacy
20
2.0 Rapid Response
18
Refugee
13
NCDs
13
Polio
12
Specific Hazards
8
Caregiver
7
Cholera
6
Health Financing Toolbox
6
Natural Hazards
4
Disability
3
Conflict
3
Global Health Education
1
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C
...
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as referen
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may
...
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the netwo
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o
...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are ad
...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of dat
...
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and
...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional
...
Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecul
...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommend
...
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analy
...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
